Companies: 10,795·Total market cap: $144.5T
Haemonetics Corporation

Haemonetics Corporation

HAENYSEHealthcare● Active
$72.45
+$1.17(+1.64%)
Market Cap$3.3B
P/E Ratio
52W High$87.32
52W Low$47.32
Overview

Haemonetics Corporation (HAE) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · HAE · as of Jun 8, 2026

Key Statistics

EPS (TTM)$2.04hae eps ttm · hae earnings per shareEarnings history
PE Ratio (TTM)35.5×hae pe ratio ttm · hae price to earningsPE Ratio deep dive
Revenue (TTM)$1.3Bhae revenue ttm · hae annual revenueFull revenue history
Dividend YieldNo Dividenddoes hae pay dividends · hae dividend yieldDividend history
Shares Outstanding47.2Mhae shares outstanding · hae floatShares outstanding history
Next EarningsAug 6, 2026Est.hae earnings date · hae next earningsEarnings history

Financial Snapshot

Full Financials
FY 2026Revenue$1.33B▼ 1.97% YoY
202420252026
haemonetics corporation revenue · hae revenue 2026
FY 2026Net Income$97.3M▼ 41.97% YoY
202420252026
haemonetics corporation net income · hae profit 2026
FY 2026EPS$2.05▼ 38.07% YoY
202420252026
hae eps · haemonetics corporation earnings per share 2026
TTM:Revenue: $1.33BNet Income: $97.3MEPS: $2.04View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy21 analystsis hae a buy · hae analyst rating
Strong Buy
0
Buy
11
Hold
10
Sell
0
Strong Sell
0
12-Month Price Target
$67.00Low
$72.45Current
$75.33Avg Target3.98% upside
$89.00High
hae price target · hae 12 month forecast

Total: 21 · Buy rate: 52.4%

The HAE analyst consensus is Buy, based on ratings from 21 Wall Street analysts over the past 3 months. The average 12-month price target is $75.33, representing +3.98% upside from the current price of $72.45.

Stock Performance

Full History
1D+1.62%
1W+9.42%
1M+31.41%
3M+12.95%
YTD-9.63%
1Y+1.10%
5Y+25.95%

About Haemonetics Corporation

CEOChristopher A. Simon
IPO DateMay 10, 1991
Employees3,657
CountryUS

Haemonetics Corporation a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma coll…

what is haemonetics corporation · hae stock overview · haemonetics corporation company profile · who is haemonetics corporation ceo · hae NYSE · haemonetics corporation headquarters · haemonetics corporation business segments

About Stock Overview & Key Data

Haemonetics Corporation (HAE) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NYSE since May 10, 1991. As of the latest trading session, HAE stock price is $72.45, with a market capitalization of $3.3B. The stock has returned +1.10% over the past 12 months and -9.63% year-to-date.

According to 21 Wall Street analysts, the consensus rating for Haemonetics Corporation stock is Buy, with an average 12-month price target of $75.33. In fiscal year 2026, Haemonetics Corporation reported revenue of $1.3B and net income of $97.3M. For detailed data — including Haemonetics Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Haemonetics Corporation (HAE) stock price is $72.45. The stock is traded on NYSE under the ticker symbol HAE. The 52-week range is $47.32 – $87.32.

HAE stock priceHAE quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice